Abstract
Abstract The need for new analogues with higher efficacy to combat the multidrug-resistant microbes as well as other health implications is the need of the hour. Medicinal chemistry has been focused highly in this regard by researchers, due to labour and redundancy of new skeletons in the conventional mode of natural product discovery. However, the less toxicity imposed by natural products would definitely provoke an interest in developing new analogues from natural sources. Microbes especially endophytes having high metabolic diversity have been an aid to attending the prerequisite clinical challenges. The insights of biosynthetic gene clusters of endophytes have proven to be more potential in drug lead discovery. The epigenetic changes in microbial biosynthetic gene clusters would envision new possible skeletal structural diversities. This review is focused on the modulation as well as activation strategies of the biosynthetic gene clusters for biosynthesizing products with pharmaceutical importance along with possible regulatory elements involved in the expression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
